Daijiworld Media Network - New Delhi
New Delhi, Nov 16: Jan Swasthya Abhiyan India (JSAI) has raised concerns over India's continuing tuberculosis (TB) burden, questioning government claims of rapid progress towards eliminating the disease and calling for greater transparency in data and stronger public health measures.
In a press release dated November 14, 2026, issued on behalf of the National Coordination Committee of JSAI, representatives Gouranga Mohapatra, Amulya Nidhi, Amitava Guha and Mehjabin Bhat highlighted findings from the World Health Organization's (WHO) Global Tuberculosis Report 2026, released on November 12.

According to the report, India recorded 2.63 lakh TB-related deaths in 2025. The country accounts for around 25 per cent of global TB cases and 23 per cent of worldwide deaths from the disease, making it the country with the highest TB burden.
India reported 25.3 lakh notified TB cases in 2025, compared with 26.18 lakh in 2024. While cases and deaths have declined marginally, JSAI said the loss of more than 2.6 lakh lives to a preventable and curable disease in a single year remains a serious public health concern.
The Union Ministry of Health and Family Welfare has highlighted a 38 per cent reduction in estimated TB mortality between 2015 and 2025, from 28 to 18 deaths per lakh population. The government has also reported a 94 per cent treatment success rate for drug-susceptible TB.
However, JSAI said these figures should not overshadow the continuing scale of deaths and suffering. It also pointed out that India achieved the WHO's interim 2020 End TB mortality milestone five years behind schedule, raising questions about the pace and effectiveness of the elimination strategy.
The organisation expressed concern over the absence of India's 2025 TB incidence estimates in the latest WHO report. The estimates have been kept under review pending technical calibration of a population-level sentinel survey conducted across 50 representative districts in 2025.
JSAI also noted that the government has not yet released the annual India TB Report, which is traditionally published around World TB Day in March and provides state- and district-level information. It said the lack of publicly available epidemiological data makes independent assessment of the country's TB burden difficult.
The organisation has called for the timely publication of raw data, transparent reporting and independent scientific scrutiny.
The WHO report has also highlighted major gaps in the diagnosis and treatment of drug-resistant TB in India. The country has the largest treatment gap globally for rifampicin-resistant TB (RR-TB), with a significant difference between the estimated number of people developing the disease and those receiving treatment.
Globally, only 42 per cent of people estimated to have developed RR-TB received treatment in 2025. JSAI attributed the continuing gaps to delays in universal drug-susceptibility testing, shortages of second-line diagnostic facilities at peripheral health centres and interruptions in treatment.
The organisation has called for stronger diagnostic infrastructure and timely access to appropriate treatment, particularly in underserved areas.
JSAI stressed that TB cannot be addressed merely as a medical problem, as its spread is closely linked to poverty, undernutrition and unsafe living and working conditions. The WHO estimates that 9.6 lakh new TB cases worldwide in 2025 were directly attributable to undernutrition.
In India, economically vulnerable communities, including daily-wage earners, informal workers, tribal and Dalit populations and migrant households, are disproportionately affected. Many patients struggle to afford nutritious food during treatment, while loss of wages, travel expenses and other household costs add to their financial burden.
The government provides Rs 1,000 per month under the Ni-kshay Poshan Yojana, along with food baskets through voluntary Ni-kshay Mitra initiatives. However, JSAI considers the assistance inadequate to meet patients' nutritional needs and protect vulnerable family members.
It also raised concerns over delays in Direct Benefit Transfers, stressing that voluntary charitable contributions cannot replace guaranteed nutritional assistance and universal social security.
The organisation drew attention to the neglect of silicosis and other occupational lung diseases among workers in mining, stone quarrying, construction, foundries and brick kilns. Silicosis increases the risk of tuberculosis, a condition commonly known as silico-tuberculosis.
JSAI warned that such cases are frequently misdiagnosed as ordinary pulmonary TB. Treating affected workers only with anti-TB medicines, without occupational health screening, can deprive them of appropriate clinical management and statutory workers' compensation.
It called for systematic screening of workers exposed to silica dust and better integration of occupational health services into TB control programmes.
The financial burden of TB treatment was another concern highlighted by the organisation. According to the WHO report, 47 per cent of TB-affected households across surveyed high-burden countries face catastrophic costs, including medical and non-medical expenses and lost wages, exceeding 20 per cent of their annual household income.
Although anti-TB medicines are available free of cost in India's public healthcare system, patients often incur expenses before diagnosis through private consultations, travel and prolonged loss of daily earnings. JSAI said these costs frequently push working-class families into debt and financial hardship.
Commenting on the findings, Amitava Guha and Mehjabin Bhat said tuberculosis was a barometer of social justice.
“India cannot eliminate TB while millions remain undernourished, underpaid and exposed to hazardous workplaces. Saving the 2.63 lakh lives lost every year requires decisive action on the social and economic determinants of health,” they said.
JSAI has urged the government to adopt a comprehensive, rights-based approach to TB elimination. Its demands include the immediate publication of the annual India TB Report, transparent epidemiological data, stronger diagnosis and treatment facilities for drug-resistant TB, adequate and timely nutritional support, and universal social security for patients and their families.
It has also called for improved screening of occupational lung diseases, measures to prevent catastrophic out-of-pocket expenditure and stronger public healthcare services to address the underlying causes of TB, including poverty, malnutrition, unemployment and hazardous working conditions.
The organisation reiterated that eliminating tuberculosis requires more than improved treatment statistics, calling for sustained public investment, accountability and action against the social and economic inequalities that continue to put millions at risk.